BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23824859)

  • 1. SCAN: a systems biology approach to pharmacogenomic discovery.
    Gamazon ER; Huang RS; Cox NJ
    Methods Mol Biol; 2013; 1015():213-24. PubMed ID: 23824859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application and interpretation of genome-wide association (GWA) studies for informing pharmacogenomic research - examples from the field of age-related macular degeneration.
    SanGiovanni JP; Rosen R; Kaushal S
    Curr Mol Med; 2014; 14(7):814-32. PubMed ID: 25109799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association studies.
    Yang TH; Kon M; DeLisi C
    Methods Mol Biol; 2013; 939():233-51. PubMed ID: 23192550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional genomics- and network-driven systems biology approaches for pharmacogenomics and toxicogenomics.
    Yang X; Zhang B; Zhu J
    Curr Drug Metab; 2012 Sep; 13(7):952-67. PubMed ID: 22591344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic functional regulatory assessment of disease-associated variants.
    Karczewski KJ; Dudley JT; Kukurba KR; Chen R; Butte AJ; Montgomery SB; Snyder M
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9607-12. PubMed ID: 23690573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy number polymorphisms and anticancer pharmacogenomics.
    Gamazon ER; Huang RS; Dolan ME; Cox NJ
    Genome Biol; 2011; 12(5):R46. PubMed ID: 21609475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GWAS Integrator: a bioinformatics tool to explore human genetic associations reported in published genome-wide association studies.
    Yu W; Yesupriya A; Wulf A; Hindorff LA; Dowling N; Khoury MJ; Gwinn M
    Eur J Hum Genet; 2011 Oct; 19(10):1095-9. PubMed ID: 21610748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In the spotlight: bioinformatics, computational biology and systems biology.
    Wang MD
    IEEE Rev Biomed Eng; 2011; 4():3-5. PubMed ID: 22273782
    [No Abstract]   [Full Text] [Related]  

  • 9. Personalized pharmacogenomics profiling using whole-genome sequencing.
    Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
    Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics for transporter pharmacogenomics and systems biology: data integration and modeling with UML.
    Yan Q
    Methods Mol Biol; 2010; 637():23-45. PubMed ID: 20419428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selecting causal genes from genome-wide association studies via functionally coherent subnetworks.
    Taşan M; Musso G; Hao T; Vidal M; MacRae CA; Roth FP
    Nat Methods; 2015 Feb; 12(2):154-9. PubMed ID: 25532137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice.
    Arbitrio M; Scionti F; Di Martino MT; Caracciolo D; Pensabene L; Tassone P; Tagliaferri P
    Clin Transl Sci; 2021 Jan; 14(1):113-119. PubMed ID: 33089968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-2 diabetes-associated variants with cross-trait relevance: Post-GWAs strategies for biological function interpretation.
    Frau F; Crowther D; Ruetten H; Allebrandt KV
    Mol Genet Metab; 2017 May; 121(1):43-50. PubMed ID: 28385534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics and bioinformatics: PharmGKB.
    Thorn CF; Klein TE; Altman RB
    Pharmacogenomics; 2010 Apr; 11(4):501-5. PubMed ID: 20350130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A guide to the current Web-based resources in pharmacogenomics.
    Glubb DM; Paugh SW; van Schaik RH; Innocenti F
    Methods Mol Biol; 2013; 1015():293-310. PubMed ID: 23824864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems genetics approaches to understand complex traits.
    Civelek M; Lusis AJ
    Nat Rev Genet; 2014 Jan; 15(1):34-48. PubMed ID: 24296534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prioritizing genetic variants for causality on the basis of preferential linkage disequilibrium.
    Zhu Q; Ge D; Heinzen EL; Dickson SP; Urban TJ; Zhu M; Maia JM; He M; Zhao Q; Shianna KV; Goldstein DB
    Am J Hum Genet; 2012 Sep; 91(3):422-34. PubMed ID: 22939045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress towards the integration of pharmacogenomics in practice.
    Mooney SD
    Hum Genet; 2015 May; 134(5):459-65. PubMed ID: 25238897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative systems biology approaches in asthma pharmacogenomics.
    Dahlin A; Tantisira KG
    Pharmacogenomics; 2012 Sep; 13(12):1387-404. PubMed ID: 22966888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of rare and low-frequency genetic variants in common disease.
    Bomba L; Walter K; Soranzo N
    Genome Biol; 2017 Apr; 18(1):77. PubMed ID: 28449691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.